share_log

Baird Initiates Coverage On TransMedics Gr With Outperform Rating, Announces Price Target of $200

Benzinga ·  Sep 24 18:24  · Ratings

Baird analyst Joe Vruwink initiates coverage on TransMedics Gr (NASDAQ:TMDX) with a Outperform rating and announces Price Target of $200.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment